Pontifical Catholic University of Argentina Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00536003
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Hospital Virgen del Carmen, provincia Buenos Aires | Paulo Brofman

Active Ingredients

Drugs in Phase 3 Trials (1)

progesterone (progestasert) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Obstetric Labor, Premature (Phase 3)

Perinatal Death (Phase 3)

Premature Birth (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1